# Vonaprazan Versus Esomeprazole for Healing of LA Grade B or Higher Esophagitis After POEM

> **NCT06955520** · NA · RECRUITING · sponsor: **Asian Institute of Gastroenterology, India** · enrollment: 300 (estimated)

## Conditions studied

- GERD

## Interventions

- **DRUG:** Vonoprazan
- **DRUG:** Esomeprazole 40mg

## Key facts

- **NCT ID:** NCT06955520
- **Lead sponsor:** Asian Institute of Gastroenterology, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-30
- **Primary completion:** 2027-12-10
- **Final completion:** 2028-12-25
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06955520

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06955520, "Vonaprazan Versus Esomeprazole for Healing of LA Grade B or Higher Esophagitis After POEM". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT06955520. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*